Fletcher Spaght Ventures
A venture capital and private equity firm investing in healthcare, life science, and information technology companies.
All edits
As of December 2019, Fletcher Spaght Ventures has made 37 investments, has 9 companies in its portfolio, and made a total of 19 exits. Notable investments made by Fletcher Spaght Ventures include: PhaseBio Pharmaceuticals, Swift Biosciences, HTG Molecular Diagnostics, Cadent, Biocius Life Sciences, HistoSonics, CardioFocus, Cheetah Medical, SurgiQuest, Cayenne Medical, and BioTrove.
Fletcher Spaght Ventures is a venture capital and private equity firm investing in healthcare, life sciencelife science, and information technology companies that is headquartered in Boston, Massachusetts and was founded in 2001 by John Fletcher and Linda Tufts.
As of December 2019, Fletcher Spaght Ventures has made 37 investments, has 9 companies in its portfolio, and made a total of 19 exits. Notable investments made by Fletcher Spaght Ventures include: PhaseBio Pharmaceuticals, Swift Biosciences, HTG Molecular Diagnostics, Cadent, Biocius Life Sciences, HistoSonics, CardioFocus, Cheetah Medical, SurgiQuest, Cayenne MedicalCayenne Medical, and BioTrove.
As of December 2019, Fletcher Spaght Ventures has made 37 investments, has 9 companies in its portfolio, and made a total of 19 exits. Notable investments made by Fletcher Spaght Ventures include: PhaseBio Pharmaceuticals, Swift Biosciences, HTG Molecular Diagnostics, CadentCadent, Biocius Life Sciences, HistoSonics, CardioFocus, Cheetah Medical, SurgiQuest, Cayenne Medical, and BioTrove.
Find more companies like Fletcher Spaght Ventures
